Skip to main content
RACS ASC 2025
Times are shown in your local time zone GMT
Combination of Lenvatinib and Pembrolizumab as neoadjuvant treatment for BRAF negative anaplastic thyroid cancer
Poster
Edit Your Submission
Edit

Poster

Presenters
Authors
Authors

Dr Jie Zhao - , Dr Bella Nguyen - , Dr Dean Lisewski -